Addressing the challenges of advanced therapy R&D
14th Oct 2019
In recent years, gene therapies, gene-modified cell therapies and cell therapies, collectively known as ‘Advanced Therapies’,...
IDBS COVID-19 Business Continuity Update, read it here.
14th Oct 2019
In recent years, gene therapies, gene-modified cell therapies and cell therapies, collectively known as ‘Advanced Therapies’,...
12th Oct 2019
Western CROs continue to up their game. They are offering unique services in a marketplace where...
3rd Oct 2019
Want to know a secret? In September we hosted a very large group of IDBS customers...
16th Sep 2019
We sat down with Chelsea Hyde, Field Marketing Manager for North America at IDBS, to find...
28th Aug 2019
We sat down with Christian Marcazzo, General Manager at IDBS, to find out what the benefits...
27th Aug 2019
The biopharmaceutical industry continues to grow and isn’t showing any signs of slowing down. Last year,...
19th Aug 2019
We sat down with J.T. Kaminski, Customer Success Manager at IDBS, to find out what i3...
12th Aug 2019
Eighty-five. That’s the number of warning letters the FDA issued in 2018 alone. And of those...
5th Aug 2019
We sat down with Brady Haggstrom, Product Manager at IDBS, to find out what i3 means,...
29th Jul 2019
The International Council of Harmonisation (ICH) has released a draft new guidance for bioanalytical method validation,...
22nd Jul 2019
Historically, small molecule pharmaceutical products dominated the medical drugs market, from treatments for diabetes to broad-spectrum...
11th Jul 2019
The importance of data integrity The research and development (R&D) industry has a responsibility to ensure...
4th Jul 2019
When you think of a medication, is the active ingredient the first thing that pops into...
27th Jun 2019
Science is based on evidence, but the scientific research field is facing a reproducibility crisis. The...
24th Jun 2019
Getting a product to market has always been a challenge. Discovering something new is just the...
13th Jun 2019
The biologics market – medicines made from biological living systems through biotechnology – is trending. There’s...
6th Jun 2019
Organizations in the biologics landscape face several challenges in the race to get their product to...
31st May 2019
When one thinks of the pharma and biopharma markets, one thing stands out – growth. In...
29th May 2019
E-WorkBook is an electronic lab notebook that forms part of the IDBS cloud-based solution to manage...
14th May 2019
We are just two weeks away from our Early Bird deadline for tickets to our i3...
9th May 2019
The biologics landscape is modern and ever-changing – and it needs innovative solutions to keep up...
7th May 2019
Samples are the essence of laboratory life. All the tests performed, equipment required, and regulations followed;...
15th Apr 2019
Without heavy investment in research and development (R&D), the millions of new and innovative medical technologies,...
In this expert interview, Debbie Barklamb, Account Manager with IDBS, explains how she works with our...
In the past, searching for experiment data has been a challenge in the R&D space. Science...
9th Apr 2019
A record number of visitors attended this year event, that ran from 2nd-5th April in Vienna....
21st Mar 2019
Are you involved in, or researching, novel bioanalytical solutions and innovations in drug discovery and development?...
Looking to explore the latest advancements in scientific processes and technology across the bioprocessing world? BioProcess...
The date when the UK should be leaving the EU, colloquially known as ‘Brexit’, is approaching...
In bioanalysis firms, there’s a lot of pressure to do more with less. This means there’s...
13th Mar 2019
In 2001, the FDA published the first version of the Bioanalytical Method Validation (BMV) Guidance for...
7th Mar 2019
Do you want to increase efficiency, enhance connectivity and drive superior quality in your lab? Then...
26th Feb 2019
Companies are facing increasing pressure to get drugs to market faster on a smaller budget. As...
Maximizing the use of IT through a digital transformation program is undoubtedly challenging for any sector....
How data, AI and machine learning can open the doors to drug discovery and advance personalized...
i3 is our annual customer and user group meeting here at IDBS. Each year the event...
20th Feb 2019
In this interview, Unjulie discusses the challenges in the current biologics scene, from business problems through...
15th Feb 2019
Sadly, Bio Innovation is over for another year. But from our perspective, the event just keeps...
22nd Jan 2019
i3 2018 saw three days of inspiration, innovation, and powerful networking with IDBS experts and fellow...
17th Dec 2018
Recent years have seen automated technologies, such as machine learning and AI, really starting to take...
The global pharma industry has always been cautious when it comes to adopting new technologies. Returns...